Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 4 of 4 found. | Sort by date

1 Lactotripeptides and antihypertensive effects: A critical review
article 2009    
Author: Boelsma, E. · Kloek, J.
Keywords: Health Nutrition · Biomedical Research · Antihypertensive effects · Blood pressure · Lactotripeptides · Milk peptides · antihypertensive agent · Beta adrenergic receptor blocking agent · Calcium antagonist · Dipeptidyl carboxypeptidase inhibitor · Lactotripeptide derivative · Placebo · Unclassified drug · Absence of side effects · Antihypertensive activity · Antihypertensive therapy · Blood chemistry · Blood pressure regulation · Caucasian · Clinical trial · Diastolic blood pressure · Dose response · Dose time effect relation · Drug bioavailability · Drug efficacy · Drug megadose · Drug potency · Drug safety · Food intake · Human · Hypertension · Japanese · Low drug dose · Nonhuman · Race difference · Review · Side effect · Systolic blood pressure · Treatment duration
[PDF] [Abstract]

2 Henoch-Schönlein purpura in children: An epidemiological study among Dutch paediatricians on incidence and diagnostic criteria
article 2007    
Author: Aalberse, J. · Dolman, K. · Ramnath, G. · Pereira, R.R. · Davin, J.C.
Keywords: Health · Jeugd en Gezondheid · antibiotic agent · dipeptidyl carboxypeptidase inhibitor · meprednisone · prednisone · antinuclear antibody · biological marker · complement component C3 · neutrophil cytoplasmic antibody · abdominal disease · adolescent · adult · anaphylactoid purpura · arthritis · controlled study · diagnostic test · epidemiological data · human tissue · incidence · infant · kidney disease · major clinical study · skin biopsy · biopsy · blood · epidemiology · immunology · Antibodies, Antineutrophil Cytoplasmic · Antibodies, Antinuclear · Biological Markers · Biopsy · Child · Complement C3 · Epidemiologic Studies · Female · Humans · Immunoglobulin A · Incidence · Kidney · Male · Netherlands · Pediatrics · Purpura, Schoenlein-Henoch · Sensitivity and Specificity · Skin
[Abstract]

3 ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis : Results from the PERTINENT study
article 2009    
Author: Ceconi, C. · Fox, K.M. · Remme, W.J. · Simoons, M.L. · Deckers, J.W. · Bertrand, M. · Parrinello, G. · Kluft, C. · Blann, A. · Cokkinos, D. · Ferrari, R.
Keywords: Health · Biomedical Research · ACE inhibition · Coronary artery disease · Inflammation · Perindopril · Thrombosis · biological marker · C reactive protein · D dimer · dipeptidyl carboxypeptidase inhibitor · fibrinogen · perindopril · placebo · tumor necrosis factor alpha · article · atherosclerosis · clinical trial · controlled clinical trial · controlled study · coronary artery disease · drug effect · drug efficacy · drug response · endothelial dysfunction · human · inflammation · major clinical study · prediction · priority journal · prognosis · survival · thrombosis · treatment duration · treatment outcome · treatment response · Angiotensin-Converting Enzyme Inhibitors · Biological Markers · C-Reactive Protein · Cardiovascular Diseases · Coronary Artery Disease · Coronary Thrombosis · Double-Blind Method · Europe · Fibrin Fibrinogen Degradation Products · Fibrinogen · Humans · Inflammation · Inflammation Mediators · Kaplan-Meiers Estimate · Perindopril · Proportional Hazards Models · Risk Assessment · Risk Factors · Time Factors · Treatment Outcome · Tumor Necrosis Factor-alpha
[Abstract]

4 Mouse models for atherosclerosis and pharmaceutical modifiers
article 2007    
Author: Zadelaar, A.S.M. · Kleemann, R. · Verschuren, L. · Vries-van der Weij, J. de · Hoorn, J. van der · Princen, H.M. · Kooistra, T.
Keywords: Biology · Biomedical Research · ACE inhibitors · AT1 receptor antagonists · Atherosclerosis · LXR · Mouse models · Pharmaceutical drugs · PPAR · Statins · atorvastatin · avasimibe · candesartan · captopril · cholesterol acyltransferase inhibitor · dipeptidyl carboxypeptidase inhibitor · hydralazine · hydroxymethylglutaryl coenzyme A reductase inhibitor · irbesartan · losartan · ly 465608 · n (2,2,2 trifluoroethyl) n [4 [2,2,2 trifluoro 1 hydroxy 1 (trifluoromethoxy)ethyl]phenyl]benzenesulfonamide · olmesartan · perindopril · peroxisome proliferator activated receptor alpha agonist · pirinixic acid · pitavastatin · pravastatin · quinapril · ramipril · rosuvastatin · simvastatin · telmisartan · temocapril · unindexed drug · valsartan · zofenopril · antihypertensive agent · antilipemic agent · apolipoprotein E · atherosclerosis · pathophysiology · sensitivity and specificity · Animals · Antihypertensive Agents · Antilipemic Agents · Apolipoproteins E · Atherosclerosis · Disease Models, Animal · Dose-Response Relationship, Drug · Drug Administration Schedule · Dyslipidemias · Humans · Hydroxymethylglutaryl-CoA Reductase Inhibitors · Hypertension · Male · Mice · Mice, Knockout · Mice, Transgenic · Sensitivity and Specificity
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 4 of 4 found. | Sort by date